Clinicians are raising concerns about proposed major changes to drug-driving laws in one Australian state, arguing that the evidence does not support the planned approach. Multiple outlets report that medical professionals have condemned the changes and called for reconsideration, stating that current research and data are insufficient to justify the scale of the legislative shift. The clinicians’ criticism focuses on whether enforcement and legal standards for driving under the influence of drugs can be applied reliably and fairly, given the underlying evidence base. The reporting describes the issue as a significant review of driving law and enforcement settings, rather than minor adjustments. While the outlets do not provide detailed technical outcomes in the brief descriptions provided, they agree on the central point: clinicians dispute the rationale for the changes and urge lawmakers to base decisions on stronger or more appropriate evidence. The proposed reforms are presented as imminent or planned, prompting the clinicians’ public alarm. The debate is therefore framed around evidence quality and the justification for legislative and enforcement changes affecting drivers.